
Global Flow Cytometry Market Report and Forecast 2024-2032
Description
Global Flow Cytometry Market Report and Forecast 2024-2032
Global Flow Cytometry Market Report and Forecast 2024-2032
Global Flow Cytometry Market Outlook
The global flow cytometry market size was valued at USD 5.3 billion in 2023, driven by increase prevalence of cancer and immunological diseases across the globe. The market size is anticipated to grow at a CAGR of 7.8% during the forecast period of 2024-2032 to achieve a value of USD 10.4 billion by 2032.
Flow Cytometry: Introduction
Flow cytometry is a powerful analytical technology used to analyze the physical and chemical characteristics of cells or particles in a fluid as it passes through at least one laser. Cell components are fluorescently labeled and then excited by the laser to emit light at varying wavelengths. The intensity of the light emitted, measured and analyzed by detectors, provides detailed information about cell size, granularity, and the abundance of biomolecules, facilitating advanced research and clinical diagnostics.
Key Trends in the Global Flow Cytometry Market
Continuous innovation in flow cytometry technology, including the development of high-throughput systems and advancements in cell sorting and analysis techniques, is enhancing the capabilities and applications of flow cytometry.
The use of flow cytometry in clinical diagnostics, drug discovery, and immunology research is expanding, driven by its ability to provide detailed cellular analysis and support personalized medicine approaches.
The rising incidence of diseases such as cancer and immunological disorders is driving the demand for flow cytometry in disease diagnosis and monitoring, as well as in research focused on understanding disease mechanisms and developing targeted therapies.
Flow cytometry is increasingly being integrated with other analytical techniques, such as mass spectrometry and molecular diagnostics, to enhance the comprehensiveness and accuracy of analysis.
Flow cytometry is finding new applications in fields such as agriculture, where it is used for cell counting, sorting, and biomarker detection in various crop species.
There's a growing trend towards developing customized flow cytometry solutions tailored to specific research and clinical needs, as well as automation of flow cytometry processes to improve efficiency and reproducibility.
Global Flow Cytometry Market Segmentation
Market Breakup by Product & Service
- Instruments
- Cell Analyzers
- Cell Sorters
- Reagents & Consumables
- Software
- Accessories
- Services
- Bead-based
- Cell-based
- Research
- Pharmaceutical & Biotechnology
Stem Cell Research
In Vitro Toxicity Testing
Apotosis
Cell Sorting
Cell Cycle Analysis
Immunology
Cell Viability
Others
- Industrial
- Clinical
- Cancer Diagnostics
- Organ Transplantation
- Autoimmune Diseases
- Hematology
- Others
- Commercial Organizations
- Biotechnology Companies
- Pharmaceutical Companies
- CRO’s
- Hospitals
- Academic Institutes
- Clinical Testing Labs
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
North America is a leading in market due to advanced healthcare infrastructure, a high prevalence of cancer, and significant investments in research and development. The United States. is particularly prominent, with numerous ongoing clinical trials and a strong focus on innovation in Flow Cytometry technologies.
Europe has a strong market, particularly in Western European countries like Germany, the UK, and France, driven by advanced healthcare systems, substantial R&D activities, and favorable regulatory environments. Increasing focus on personalized medicine and cancer screening programs contributes to the growth of the Flow Cytometry market.
Asia-Pacific is the fastest-growing region, driven by rising cancer prevalence, improving healthcare infrastructure, and increasing investments in healthcare technologies. Countries like China and Japan are heavily investing in healthcare technology, including Flow Cytometry, and are becoming significant markets in the region.
Latin America has become an emerging market with growing awareness of cancer and its early detection. Investments in healthcare infrastructure and increasing accessibility to advanced medical technologies are driving the market growth in this region.
Middle East & Africa came out as a gradual growth in the market, influenced by improving healthcare facilities and increasing awareness about non-invasive diagnostic methods. The market growth is primarily concentrated in urban and more developed parts of the region.
Global Flow Cytometry Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Danaher Corp.
- Becton, Dickinson, and Company (BD)
- Sysmex Corp.
- Agilent Technologies, Inc.
- Apogee Flow Systems Ltd.
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific, Inc.
- Stratedigm, Inc.
- DiaSorin SpA
- Miltenyi Biotec
- Sony Biotechnology, Inc.
*Please Note:* The report will take 7 business days to complete, after order confirmation.
Table of Contents
140 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Flow Cytometry Market Overview
- 3.1 Global Flow Cytometry Market Historical Value (2017-2023)
- 3.2 Global Flow Cytometry Market Forecast Value (2024-2032)
- 4 Global Flow Cytometry Market Landscape
- 4.1 Global Flow Cytometry Developers Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 Global Flow Cytometry Product Landscape
- 4.2.1 Analysis by Product
- 4.2.2 Analysis by Technology
- 4.2.3 Analysis by Application
- 4.2.4 Analysis by End-use
- 5 Global Flow Cytometry Market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.3 Porter’s Five Forces Model
- 5.4 Key Demand Indicators
- 5.5 Key Price Indicators
- 5.6 Industry Events, Initiatives, and Trends
- 5.7 Value Chain Analysis
- 6 Global Flow Cytometry Market Segmentation
- 6.1 Global Flow Cytometry Market by Product & Services
- 6.1.1 Market Overview
- 6.1.2 Instruments
- 6.1.2.1 Cell Analysers
- 6.1.2.2 Cell Sorters
- 6.1.3 Reagents & Consumables
- 6.1.4 Software
- 6.1.5 Accessories
- 6.1.6 Services
- 6.2 Global Flow Cytometry Market by Technology
- 6.2.1 Market Overview
- 6.2.2 Bead-based
- 6.2.3 Cell-based
- 6.3 Global Flow Cytometry Market by Application
- 6.3.1 Market Overview
- 6.3.2 Research
- 6.3.2.1 Pharmaceutical & Biotechnology
- 6.3.2.1.1 Drug Discovery
- 6.3.2.1.2 Stem Cell Research
- 6.3.2.1.3 In Vitro Toxicity Testing
- 6.3.2.2 Apotosis
- 6.3.2.3 Cell Sorting
- 6.3.2.4 Cell Cycle Analysis
- 6.3.2.5 Immunology
- 6.3.2.6 Cell Viability
- 6.3.2.7 Others
- 6.3.3 Industrial
- 6.3.4 Clinical
- 6.3.4.1 Cancer Diagnostics
- 6.3.4.2 Organ Transplantation
- 6.3.4.3 Autoimmune Diseases
- 6.3.4.4 Hematology
- 6.3.4.5 Others
- 6.4 Global Flow Cytometry Market by End-use
- 6.4.1 Market Overview
- 6.4.2 Commercial Organizations
- 6.4.3 Biotechnology Companies
- 6.4.4 Pharmaceutical Companies
- 6.4.5 CRO’s
- 6.4.6 Hospitals
- 6.4.7 Academic Institutes
- 6.4.8 Clinical Testing Labs
- 6.5 Global Flow Cytometry Market by Region
- 6.5.1 Market Overview
- 6.5.2 North America
- 6.5.3 Europe
- 6.5.4 Asia Pacific
- 6.5.5 Latin America
- 6.5.6 Middle East and Africa
- 7 North America Flow Cytometry Market
- 7.1 Market Share by Country
- 7.2 United States of America
- 7.3 Canada
- 8 Europe Flow Cytometry Market
- 8.1 Market Share by Country
- 8.2 United Kingdom
- 8.3 Germany
- 8.4 France
- 8.5 Italy
- 8.6 Others
- 9 Asia Pacific Flow Cytometry Market
- 9.1 Market Share by Country
- 9.2 China
- 9.3 Japan
- 9.4 India
- 9.5 ASEAN
- 9.6 Others
- 10 Latin America Flow Cytometry Market
- 10.1 Market Share by Country
- 10.2 Brazil
- 10.3 Argentina
- 10.4 Mexico
- 10.5 Others
- 11 Middle East and Africa Flow Cytometry Market
- 11.1 Market Share by Country
- 11.2 Saudi Arabia
- 11.3 United Arab Emirates
- 11.4 Nigeria
- 11.5 South Africa
- 11.6 Others
- 12 Patent Analysis
- 12.1 Analysis by Type of Patent
- 12.2 Analysis by Publication year
- 12.3 Analysis by Issuing Authority
- 12.4 Analysis by Patent Age
- 12.5 Analysis by CPC Analysis
- 12.6 Analysis by Patent Valuation
- 12.7 Analysis by Key Players
- 13 Grants Analysis
- 13.1 Analysis by Year
- 13.2 Analysis by Amount Awarded
- 13.3 Analysis by Issuing Authority
- 13.4 Analysis by Grant Application
- 13.5 Analysis by Funding Institute
- 13.6 Analysis by NIH Departments
- 13.7 Analysis by Recipient Organization
- 14 Funding and Investment Analysis
- 14.1 Analysis by Funding Instances
- 14.2 Analysis by Type of Funding
- 14.3 Analysis by Funding Amount
- 14.4 Analysis by Leading Players
- 14.5 Analysis by Leading Investors
- 14.6 Analysis by Geography
- 15 Partnership and Collaborations Analysis
- 15.1 Analysis by Partnership Instances
- 15.2 Analysis by Type of Partnership
- 15.3 Analysis by Leading Players
- 15.4 Analysis by Geography
- 16 Regulatory Framework
- 16.1 Regulatory Overview
- 16.2 US FDA
- 16.3 EU EMA
- 16.4 INDIA CDSCO
- 16.5 JAPAN PMDA
- 16.6 Others
- 17 Supplier Landscape
- 17.1 Danaher Corp.
- 17.1.1 Financial Analysis
- 17.1.2 Product Portfolio
- 17.1.3 Demographic Reach and Achievements
- 17.1.4 Mergers and Acquisitions
- 17.1.5 Certifications
- 17.2 Becton, Dickinson, and Company (BD)
- 17.2.1 Financial Analysis
- 17.2.2 Product Portfolio
- 17.2.3 Demographic Reach and Achievements
- 17.2.4 Mergers and Acquisitions
- 17.2.5 Certifications
- 17.3 Beckman Coulter, Inc.
- 17.3.1 Financial Analysis
- 17.3.2 Product Portfolio
- 17.3.3 Demographic Reach and Achievements
- 17.3.4 Mergers and Acquisitions
- 17.3.5 Certifications
- 17.4 Sysmex Corp.
- 17.4.1 Financial Analysis
- 17.4.2 Product Portfolio
- 17.4.3 Demographic Reach and Achievements
- 17.4.4 Mergers and Acquisitions
- 17.4.5 Certifications
- 17.5 Agilent Technologies, Inc.
- 17.5.1 Financial Analysis
- 17.5.2 Product Portfolio
- 17.5.3 Demographic Reach and Achievements
- 17.5.4 Mergers and Acquisitions
- 17.5.5 Certifications
- 17.6 Apogee Flow Systems Ltd.
- 17.6.1 Financial Analysis
- 17.6.2 Product Portfolio
- 17.6.3 Demographic Reach and Achievements
- 17.6.4 Mergers and Acquisitions
- 17.6.5 Certifications
- 17.7 Bio-Rad Laboratories, Inc.
- 17.7.1 Financial Analysis
- 17.7.2 Product Portfolio
- 17.7.3 Demographic Reach and Achievements
- 17.7.4 Mergers and Acquisitions
- 17.7.5 Certifications
- 17.8 Thermo Fisher Scientific, Inc.
- 17.8.1 Financial Analysis
- 17.8.2 Product Portfolio
- 17.8.3 Demographic Reach and Achievements
- 17.8.4 Mergers and Acquisitions
- 17.8.5 Certifications
- 17.9 Stratedigm, Inc.
- 17.9.1 Financial Analysis
- 17.9.2 Product Portfolio
- 17.9.3 Demographic Reach and Achievements
- 17.9.4 Mergers and Acquisitions
- 17.9.5 Certifications
- 17.10 DiaSorin SpA
- 17.10.1 Financial Analysis
- 17.10.2 Product Portfolio
- 17.10.3 Demographic Reach and Achievements
- 17.10.4 Mergers and Acquisitions
- 17.10.5 Certifications
- 17.11 Miltenyi Biotec
- 17.11.1 Financial Analysis
- 17.11.2 Product Portfolio
- 17.11.3 Demographic Reach and Achievements
- 17.11.4 Mergers and Acquisitions
- 17.11.5 Certifications
- 17.12 Sony Biotechnology, Inc.
- 17.12.1 Financial Analysis
- 17.12.2 Product Portfolio
- 17.12.3 Demographic Reach and Achievements
- 17.12.4 Mergers and Acquisitions
- 17.12.5 Certifications
- 17.13 Merck KGaA
- 17.13.1 Financial Analysis
- 17.13.2 Product Portfolio
- 17.13.3 Demographic Reach and Achievements
- 17.13.4 Mergers and Acquisitions
- 17.13.5 Certifications
- 17.14 Luminex Corporation
- 17.14.1 Financial Analysis
- 17.14.2 Product Portfolio
- 17.14.3 Demographic Reach and Achievements
- 17.14.4 Mergers and Acquisitions
- 17.14.5 Certifications
- 17.15 Nanocellect Biomedical
- 17.15.1 Financial Analysis
- 17.15.2 Product Portfolio
- 17.15.3 Demographic Reach and Achievements
- 17.15.4 Mergers and Acquisitions Certifications
- 18 Global Flow Cytometry Market - Distribution Model (Additional Insight)
- 18.1 Overview
- 18.2 Potential Distributors
- 18.3 Key Parameters for Distribution Partner Assessment
- 19 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 20 Company Competitiveness Analysis (Additional Insight)
- 20.1 Very Small Companies
- 20.2 Small Companies
- 20.3 Mid-Sized Companies
- 20.4 Large Companies
- 20.5 Very Large Companies
- 21 Payment Methods (Additional Insight)
- 21.1 Government Funded
- 21.2 Private Insurance
- 21.3 Out-of-Pocket
- *Additional insights provided are customisable as per client requirements.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.